Toll-like receptor 2 promotes breast cancer progression and resistance to chemotherapy.
Oncoimmunology
; 11(1): 2086752, 2022.
Article
in En
| MEDLINE
| ID: mdl-35756841
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Breast Neoplasms
/
Toll-Like Receptor 2
Limits:
Animals
/
Female
/
Humans
Language:
En
Journal:
Oncoimmunology
Year:
2022
Document type:
Article
Affiliation country:
Italia
Country of publication:
Estados Unidos